JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M503780200 on May 17, 2005

J. Biol. Chem., Vol. 280, Issue 34, 30273-30281, August 26, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/34/30273    most recent
M503780200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Srivastava, S. K.
Right arrow Articles by Ramachandran, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Srivastava, S. K.
Right arrow Articles by Ramachandran, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

NAD+-dependent DNA Ligase (Rv3014c) from Mycobacterium tuberculosis

CRYSTAL STRUCTURE OF THE ADENYLATION DOMAIN AND IDENTIFICATION OF NOVEL INHIBITORS*

Sandeep Kumar Srivastava{ddagger}§, Rama Pati Tripathi¶, and Ravishankar Ramachandran{ddagger}||

From the Divisions {ddagger}Molecular and Structural Biology and Medicinal and Process Chemistry, Central Drug Research Institute, Chattar Manzil, Mahatma Gandhi Marg, Lucknow-226001, India

DNA ligases utilize either ATP or NAD+ as cofactors to catalyze the formation of phosphodiester bonds in nicked DNA. Those utilizing NAD+ are attractive drug targets because of the unique cofactor requirement for ligase activity. We report here the crystal structure of the adenylation domain of the Mycobacterium tuberculosis NAD+-dependent ligase with bound AMP. The adenosine nucleoside moiety of AMP adopts a syn-conformation. The structure also captures a new spatial disposition between the two subdomains of the adenylation domain. Based on the crystal structure and an in-house compound library, we have identified a novel class of inhibitors for the enzyme using in silico docking calculations. The glycosyl ureide-based inhibitors were able to distinguish between NAD+- and ATP-dependent ligases as evidenced by in vitro assays using T4 ligase and human DNA ligase I. Moreover, assays involving an Escherichia coli strain harboring a temperature-sensitive ligase mutant and a ligase-deficient Salmonella typhimurium strain suggested that the bactericidal activity of the inhibitors is due to inhibition of the essential ligase enzyme. The results can be used as the basis for rational design of novel antibacterial agents.


Received for publication, April 7, 2005 , and in revised form, May 10, 2005.

The atomic coordinates and structure factors (code 1ZAU) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).

* The work was supported in part by Department of Biotechnology Grant SSP0139 and Council for Scientific and Industrial Research Network Grant CMM0017. This is Communication 6757 from the Central Drug Research Institute. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Recipient of junior and senior research fellowships from the Council for Scientific and Industrial Research.

|| To whom correspondence should be addressed: Molecular and Structural Biology Div., Central Drug Research Institute, P. O. Box 173, Chattar Manzil, Mahatma Gandhi Marg, Lucknow-226001, India. Tel.:91-522-261-2411 (ext. 4442); Fax: 91-522-262-3405; E-mail: ravi_anitha{at}yahoo.com.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
M. Korycka-Machala, E. Rychta, A. Brzostek, H. R. Sayer, A. Rumijowska-Galewicz, R. P. Bowater, and J. Dziadek
Evaluation of NAD+-Dependent DNA Ligase of Mycobacteria as a Potential Target for Antibiotics
Antimicrob. Agents Chemother., August 1, 2007; 51(8): 2888 - 2897.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
H. Zhu and S. Shuman
Characterization of Agrobacterium tumefaciens DNA ligases C and D
Nucleic Acids Res., June 28, 2007; 35(11): 3631 - 3645.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Akey, A. Martins, J. Aniukwu, M. S. Glickman, S. Shuman, and J. M. Berger
Crystal Structure and Nonhomologous End-joining Function of the Ligase Component of Mycobacterium DNA Ligase D
J. Biol. Chem., May 12, 2006; 281(19): 13412 - 13423.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. K. Srivastava, D. Dube, N. Tewari, N. Dwivedi, R. P. Tripathi, and R. Ramachandran
Mycobacterium tuberculosis NAD+-dependent DNA ligase is selectively inhibited by glycosylamines compared with human DNA ligase I
Nucleic Acids Res., December 15, 2005; 33(22): 7090 - 7101.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.